Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke
A Double-Blind, Randomized, Placebo- Controlled Study Of Atorvastatin As Prevention Of Cerebrovascular Events In Patients With A Previous Transient Ischemic Attack (TIA) Or Stroke
Sponsor: Pfizer
Listed as NCT00147602, this PHASE4 trial focuses on Cardiovascular Disease and remains completed. Sponsored by Pfizer, it has been updated 6 times since 1998, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Nov 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aarau, Switzerland, Aberdeen, United Kingdom, Alicante, Spain, Almelo, Netherlands, Athens, Greece, Auckland, New Zealand, Bad Rodach, Germany, Barcelona, Spain, Bari, Italy, Basel, Switzerland and 106 more location s